Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,892 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04014530 | Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study(ATAPEMBRO) | recruiting | Phase 1 / Phase 2 | 47 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05240950 | Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases | recruiting | Phase 1 | 18 | Changhai HospitalOTHER | 1 |
| Mar 11, 2022 |
| clinicaltrials |
| NCT04991948 | Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer | recruiting | Phase 1 | 34 | Celyad Oncology SAINDUSTRY | 2 | Mar 9, 2022 | clinicaltrials |
| NCT03692429 | alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells(alloSHRINK) | recruiting | Phase 1 | 49 | Celyad Oncology SAINDUSTRY | 2 | Nov 20, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Feb 1, 2023source: clinicaltrials